Suzhou Novoprotein Scientific Co. Ltd. A
Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania. It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, enzymes and reagents, biosimilar reference antibodies, gene and cell therapy, molecular … Read more
Suzhou Novoprotein Scientific Co. Ltd. A - Asset Resilience Ratio
Suzhou Novoprotein Scientific Co. Ltd. A (688137) has an Asset Resilience Ratio of 27.04% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2023)
This chart shows how Suzhou Novoprotein Scientific Co. Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Suzhou Novoprotein Scientific Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥621.70 Million | 27.04% |
| Total Liquid Assets | CN¥621.70 Million | 27.04% |
Asset Resilience Insights
- Very High Liquidity: Suzhou Novoprotein Scientific Co. Ltd. A maintains exceptional liquid asset reserves at 27.04% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Suzhou Novoprotein Scientific Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Suzhou Novoprotein Scientific Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Suzhou Novoprotein Scientific Co. Ltd. A (2020–2023)
The table below shows the annual Asset Resilience Ratio data for Suzhou Novoprotein Scientific Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 27.04% | CN¥621.70 Million | CN¥2.30 Billion | -14.39pp |
| 2022-12-31 | 41.43% | CN¥966.85 Million | CN¥2.33 Billion | +27.83pp |
| 2020-12-31 | 13.61% | CN¥25.14 Million | CN¥184.79 Million | -- |